+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Combination Vaccine & Multivalent Vaccine Market - Global Forecast 2026-2032- Product Image
Veterinary Combination Vaccine & Multivalent Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Combination Vaccine & Multivalent Vaccine Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134376
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Combination Vaccine & Multivalent Vaccine Market is projected to reach USD 11.91 Billion in 2026. It is expected to continue growing at a CAGR of 7.94%, reaching USD 18.77 Billion by 2032.

Veterinary Combination and Multivalent Vaccines: Executive Overview

Veterinary combination and multivalent vaccines consolidate protection against multiple pathogens into fewer administrations for companion animals, livestock, and aquaculture. Their value is linked to disease prevention, vaccination compliance, operational efficiency, animal welfare, and reduced production disruption. Adoption is shaped by pathogen prevalence, veterinary infrastructure, regulatory requirements, cold-chain reliability, diagnostic capacity, and confidence in vaccine safety and effectiveness.

Prevention Is Shifting Toward Integrated, Program-Based Protection

The landscape is moving from single-disease interventions toward coordinated vaccination programs aligned with species, age, geography, production systems, and exposure risk. Combination products can simplify schedules and support coverage where veterinary access is constrained, while multivalent formulations help address co-circulating pathogens. Greater attention is also being placed on stewardship, surveillance, traceability, post-vaccination monitoring, and minimizing unnecessary handling of animals.

Artificial Intelligence Strengthens Surveillance, Formulation, and Delivery Decisions

Artificial intelligence can improve veterinary vaccine programs by identifying disease signals from clinical records, laboratory results, mobility data, and farm-level observations. Predictive tools may support risk-based vaccination planning, cold-chain monitoring, adverse-event detection, and prioritization of diagnostic testing. In research and development, machine learning can assist antigen selection and formulation analysis, but deployment requires representative datasets, transparent validation, cybersecurity, and continued expert oversight. AI should augment-not replace-veterinary judgment and regulatory review.

Regional Insights: Infrastructure and Disease Pressure Shape Adoption

North America combines mature veterinary services, established companion-animal care, and sophisticated livestock biosecurity, supporting demand for convenient and evidence-based vaccination schedules. Latin America’s adoption is influenced by commercial livestock systems, zoonotic-disease priorities, affordability, and uneven access to veterinary services. Europe emphasizes regulatory compliance, animal welfare, surveillance, and harmonized disease-control practices. The Middle East requires solutions adapted to cross-border animal movement, climatic stress, and livestock health priorities, while Africa’s needs vary widely with veterinary access, mobile herds, endemic disease burden, and cold-chain limitations. Asia-Pacific presents diverse requirements across intensive livestock, aquaculture, companion animals, and rapidly developing veterinary systems, with manufacturing and distribution capacity differing substantially by country.

Group Insights: Trade, Regulation, and Security Networks Matter

ASEAN markets benefit from cooperation on transboundary animal diseases, but implementation differs across veterinary systems and island or mainland logistics. BRICS members span major livestock, companion-animal, and vaccine-manufacturing environments, creating opportunities for coordinated surveillance while retaining distinct regulatory pathways. The European Union supports common principles for authorization, surveillance, and animal health, although national delivery practices remain important. G7 countries generally have strong research, diagnostic, and regulatory capabilities, with emphasis on product quality and antimicrobial stewardship. GCC markets prioritize import reliability, livestock protection, and climate-adapted veterinary services. NATO members are relevant to biosecurity and cross-border preparedness, including continuity of animal-health supply chains during emergencies.

Country Insights: Diverse Priorities Across Fifteen National Markets

Australia emphasizes livestock biosecurity, extensive production systems, and protection from exotic disease incursions. Brazil combines large-scale animal production with strong requirements for herd health, traceability, and export-oriented disease control. Canada and the United States rely on advanced veterinary networks while addressing regional production differences and companion-animal demand. China and India require solutions suited to large and diverse livestock populations, expanding veterinary access, and varied regulatory and distribution conditions. Japan and South Korea place emphasis on regulated animal health, disease prevention, and technologically enabled care. France, Germany, Italy, and Spain operate within European regulatory frameworks while reflecting distinct livestock, companion-animal, and regional disease priorities. The United Kingdom maintains strong biosecurity and surveillance requirements following changes to its trading and regulatory environment. Mexico’s priorities include livestock productivity, border-related disease control, and access across varied farming systems. Russia’s animal-health planning is influenced by domestic production, regional disease patterns, and supply-chain resilience.

Actions for Leaders: Build Evidence, Resilience, and Program Fit

Industry leaders should segment products and services by species, pathogen profile, production model, and veterinary-access conditions rather than treating combination vaccination as a uniform category. They should generate comparative evidence on safety, immunogenicity, duration of protection, schedule simplification, and field performance, supported by transparent post-market surveillance. Distribution strategies should strengthen cold-chain visibility, local training, inventory resilience, and digital traceability. Partnerships with veterinarians, producers, diagnostic laboratories, regulators, and public-health authorities can improve uptake and trust. AI investments should begin with clearly governed use cases, validated data, human review, and measurable operational outcomes.

Research Methodology: Evidence-Based Market Structuring Without Unsupported Quantification

This executive summary uses a structured qualitative framework for veterinary combination and multivalent vaccines. It assesses product utility, disease-prevention needs, species applications, regulatory and surveillance conditions, veterinary infrastructure, logistics, and regional operating environments. Regional, group, and country perspectives are integrated using the specified geographies and are framed around observable industry drivers and constraints. No market estimates, market shares, forecasts, or company-specific claims are used; conclusions should be validated against current regulatory documents, veterinary disease surveillance, peer-reviewed evidence, and field-level performance data before strategic decisions are made.

Conclusion: Integrated Vaccination Supports More Efficient Animal Health Programs

Veterinary combination and multivalent vaccines are positioned at the intersection of disease prevention, animal welfare, production continuity, and practical veterinary delivery. Their effectiveness depends not only on formulation, but also on surveillance, diagnostics, regulation, cold-chain execution, professional confidence, and fit with local vaccination programs. Leaders that combine rigorous evidence with regionally adapted implementation, resilient supply chains, and responsible digital tools will be better placed to strengthen animal-health outcomes across diverse markets.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Animal Type
7.1. Introduction
7.2. Aquatic
7.3. Companion Animals
7.3.1. Cats
7.3.2. Dogs
7.4. Equine
7.5. Livestock
7.5.1. Cattle
7.5.2. Poultry
7.5.3. Sheep & Goat
7.5.4. Swine
7.6. Wildlife
7.6.1. Deer
7.6.2. Furbearers
8. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Product Type
8.1. Introduction
8.2. Conjugate Vaccine
8.3. Inactivated Vaccine
8.4. Live Attenuated Vaccine
8.5. Recombinant Vaccine
8.6. Toxoid Vaccine
9. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Intranasal
9.4. Oral
9.5. Subcutaneous
10. Veterinary Combination Vaccine & Multivalent Vaccine Market, by End User
10.1. Introduction
10.2. Animal Farms
10.2.1. Cattle Farms
10.2.2. Poultry Farms
10.2.3. Swine Farms
10.3. Research Institutes
10.4. Veterinary Hospitals & Clinics
11. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online
12. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Bimeda Biologicals
16.2. Biogénesis Bagó S.A.
16.3. Boehringer Ingelheim International GmbH
16.4. Ceva Santé Animale
16.5. Dechra Pharmaceuticals PLC
16.6. Elanco Animal Health Incorporated
16.7. Hester Biosciences Limited
16.8. HIPRA, S.A.
16.9. Huvepharma, Inc.
16.10. Indian Immunologicals Limited
16.11. Merck & Co., Inc.
16.12. Phibro Animal Health Corporation
16.13. Vaxxinova
16.14. Virbac S.A.
16.15. Zoetis Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Years Considered for the Study
FIGURE 2. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Research Design
FIGURE 3. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Research Framework
FIGURE 4. Global Veterinary Combination Vaccine & Multivalent Vaccine Market, Data Triangulation
FIGURE 5. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 7. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Segmentation & Coverage
TABLE 2. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 4. Global Aquatic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Aquatic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Aquatic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Equine Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Equine Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Equine Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Sheep & Goat Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Sheep & Goat Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Sheep & Goat Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Wildlife Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Wildlife Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Wildlife Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Deer Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Deer Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Deer Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Furbearers Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Furbearers Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Furbearers Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 44. Global Conjugate Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Conjugate Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Conjugate Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Inactivated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Inactivated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Inactivated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Toxoid Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Toxoid Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Toxoid Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 60. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Intranasal Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Intranasal Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Intranasal Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Global Animal Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Animal Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Animal Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Cattle Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Cattle Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Cattle Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Poultry Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Poultry Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Poultry Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Swine Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Swine Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Swine Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Veterinary Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Veterinary Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Veterinary Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 114. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 115. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 116. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 117. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 119. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 121. North America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 124. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 125. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 126. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 127. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 129. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 131. Latin America Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 134. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 135. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 136. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 137. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 139. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 141. Europe Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 144. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 145. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 146. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 147. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 149. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 151. Middle East Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 154. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 155. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 156. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 157. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 159. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 161. Africa Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 165. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 166. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 167. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 168. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 170. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 172. ASEAN Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 175. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 176. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 177. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 178. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 180. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 182. GCC Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 185. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 186. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 187. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 188. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 192. European Union Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 195. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 196. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 197. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 198. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 200. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 202. BRICS Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 205. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 206. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 207. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 208. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 210. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 212. G7 Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 215. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 216. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 217. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 218. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 220. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 222. NATO Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Global Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 224. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 225. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 226. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 227. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 228. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 229. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 231. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 233. United States Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 235. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 236. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 237. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 238. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 239. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 241. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 243. Canada Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 245. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 246. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 247. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 248. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 249. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 251. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 253. Mexico Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 255. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 256. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 257. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 258. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 259. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 261. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 263. Brazil Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 265. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 266. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 267. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 268. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 269. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 271. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 273. United Kingdom Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 274. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 275. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 276. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 277. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 278. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 279. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 280. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 281. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 283. Germany Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 285. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 286. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 287. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 288. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Wildlife, 2017-2032 (USD Million)
TABLE 289. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 291. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Farms, 2017-2032 (USD Million)
TABLE 293. France Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. Russia Veterinary Combination Vaccine & Multivalent Vaccine Market Size, 2017-2032 (USD Million)
TABLE 295. Russia Veterinary Combination Vaccine & Multivalent Vaccine Market Size, by Animal Ty

Companies Mentioned

  • Bimeda Biologicals
  • Biogénesis Bagó S.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA, S.A.
  • Huvepharma, Inc.
  • Indian Immunologicals Limited
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Vaxxinova
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Veterinary/Animal Vaccines Market - Global Forecast 2026-2032 - Product Image

Veterinary/Animal Vaccines Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Rabies Vaccines for Animals Market - Global Forecast 2026-2032 - Product Image

Rabies Vaccines for Animals Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Veterinary Vaccines Market Outlook 2026-2034: Market Share, and Growth Analysis by Animal Type, Technology, Disease Indication, Route of Administration - Product Image

Veterinary Vaccines Market Outlook 2026-2034: Market Share, and Growth Analysis by Animal Type, Technology, Disease Indication, Route of Administration

  • Report
  • 160 Pages
  • Global
From
Porcine Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Porcine Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Canine influenza Vaccines Market - Global Strategic Business Report - Product Image

Canine influenza Vaccines Market - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.